- Research Article
- 10.1016/j.critrevonc.2026.105159
Circular RNA-mediated tumor immune escape: Mechanistic architecture and nanomedicine-enabled therapeutic reprogramming.
- Apr 01, 2026
- Critical reviews in oncology/hematology
- Shenyi Jiang + 5 more +5
Publications from 2021 to 2026
Showing 10 of 492 papers
Circular RNA-mediated tumor immune escape: Mechanistic architecture and nanomedicine-enabled therapeutic reprogramming.
The Sirt2-Nur77 axis regulates muscle stem cell quiescence and senescence via epigenetic-metabolic synergy.
Nur77 expression decreases with age in multiple organs, including the liver, brain, heart, and kidney, whereas Sirt2 increases with age in the mouse cerebral cortex and hippocampus. We identified the central role of the Sirt2-P300/Nur77/K310 acetylation axis in regulating muscle homeostasis and regeneration and its age-related alterations. Consistently, we observed reduced Nur77 and elevated Sirt2 expression in aging skeletal muscle, particularly the anterior tibialis, which is enriched in type IIB and IIA fast-twitch fibers. Mechanistically, Sirt2 promoted Nur77 degradation via K310-specific deacetylation, weakening Myf5 transcriptional activity and altering satellite cell metabolic heterogeneity. Functional tests showed that Sirt2 inhibition (AGK2) or Nur77 activation (CSNB) improved muscle function in aged mice, whereas the K310R mutation led to muscle atrophy and impaired regeneration. These findings suggest the Sirt2-P300/Nur77 axis as a potential therapeutic target for skeletal muscle aging and anti-sarcopenia drug development.
Read moreCliCARE: Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records
Large Language Models (LLMs) hold significant promise for improving clinical decision support and reducing physician burnout by synthesizing complex, longitudinal cancer Electronic Health Records (EHRs). However, their implementation in this critical field faces three primary challenges: the inability to effectively process the extensive length and fragmented nature of patient records for accurate temporal analysis; a heightened risk of clinical hallucination, as conventional grounding techniques such as Retrieval-Augmented Generation (RAG) do not adequately incorporate process-oriented clinical guidelines; and unreliable evaluation metrics that hinder the validation of AI systems in oncology. To address these issues, we propose CliCARE, a framework for Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records. The framework operates by transforming unstructured, longitudinal EHRs into patient-specific Temporal Knowledge Graphs (TKGs) to capture long-range dependencies, and then grounding the decision support process by aligning these real-world patient trajectories with a normative guideline knowledge graph. This approach provides oncologists with evidence-grounded decision support by generating a high-fidelity clinical summary and an actionable recommendation. We validated our framework using large-scale, longitudinal data from a private Chinese cancer dataset and the public English MIMIC-IV dataset. In these settings, CliCARE significantly outperforms baselines, including leading long-context LLMs and Knowledge Graph-enhanced RAG methods. The clinical validity of our results is supported by a robust evaluation protocol, which demonstrates a high correlation with assessments made by oncologists.
Read moreCT4CMS: Preoperative Computed Tomography-Based Consensus Molecular Subtyping Prediction in Colorectal Cancer Using Interpretable Deep Learning
Abstract Consensus molecular subtyping (CMS) defines the transcriptomic taxonomy of colorectal cancer (CRC) and guides precision therapy. Although current approaches can predict CMS from histopathology, they rely on surgical specimens, limiting their preoperative applicability. In this study, we developed a deep learning model to infer CMS directly from preoperative computed tomography (CT) scans, enabling noninvasive molecular stratification of CRC. A multi-institutional cohort of 2,444 CRC patients was collected from the Sixth Affiliated Hospital of Sun Yat-sen University and Liaoning Cancer Hospital, comprising a discovery cohort ( n = 416), an internal validation cohort ( n = 1,671), and an external validation cohort ( n = 357). To achieve robust feature extraction, a self-supervised 3D representation learning network was first pretrained on large-scale public CT datasets to capture generalizable imaging features. These representations were subsequently integrated into a multi-instance learning (MIL) classifier for CMS prediction, with attention mechanisms to enhance interpretability. Model performance was evaluated by cross-validation on the discovery cohort and verified on the two validation cohorts. CT4CMS demonstrated strong performance in predicting CMS subtypes directly from CT scans, achieving a cross-validation AUC of 0.867. In both validation cohorts, patients predicted as CMS4 exhibited significantly poorer disease-free survival yet derived substantial benefit from adjuvant chemotherapy, consistent with transcriptome-defined subtyping trends observed in the discovery cohort. Interpretability analysis revealed distinct subtype-specific radiomic features, suggesting that CT-derived imaging features capture underlying molecular characteristics and enable CMS classification. Overall, this study establishes a noninvasive and interpretable deep learning framework for CMS prediction in CRC, paving the way for imaging-based molecular stratification and personalized therapeutic decision-making.
Read moreCorrection: Single-atom Ca nanozyme induces glioma death through Ca2+-overload-enhanced catalytic tumor nanotherapy, ferroptosis and synergistic remodeling of the immune microenvironment.
updated Fig. 8C.The authors also noted inconsistent labeling in Figs. 1 and2.Owing to differences in figureassembly practices among early team members, the LN229 cell line was incorrectly labeled as "LN229-GSC" in certain panels (specifically, Fig. 1E andG, 1 H, and 2B, 2 C).The figures have now been corrected in the original publication.
Read moreEfficacy of alpha-lipoic acid in mitigating neuropathic pain: mechanistic insights and therapeutic implications.
Neuropathic pain (NP), affecting 7-10% of the general population, results from damage to the somatosensory nervous system and leads to persistent discomfort, functional limitations, and psychological distress. This study investigates the analgesic effects of alpha-lipoic acid (ALA) on neuropathic pain management and elucidates the underlying biological mechanisms. A neuropathic pain model was induced via spinal nerve ligation (SNL), and pain behaviours were evaluated following intraperitoneal ALA injections at doses of 50, 100, and 200mg/kg. Immunofluorescence assessed the activation of glia cells in the spinal L4 segment and dorsal root ganglia, while cytokine levels were measured to evaluate inflammatory responses. Mitochondrial integrity was analysed with Transmission Electron Microscopy, and oxidative stress indicators were assessed through western blotting. Results showed that SNL mice exhibited heightened pain sensitivity, which was significantly reduced with ALA administration, improving both mechanical and thermal hyperalgesia. ALA treatment suppressed pro-inflammatory mediators, enhanced mitochondrial integrity, and decreased mitochondrial fission. Elevated oxidative stress markers were reduced, with ALA mitigating caspase-9, caspase-3, and Bax activity while promoting Bcl-2 expression. Additionally, ALA enhanced the level of PPAR-γ, facilitated the nuclear translocation of Nrf2 and inhibited NF-κB activation, leading to increased antioxidant levels and reduced inflammation. Thus, ALA effectively alleviated pain sensitivity and oxidative stress, improved mitochondrial structure, and decreased apoptosis, highlighting its potential as a promising therapeutic strategy for neuropathic pain management.
Read moreRelease-Independent Transcription from Covalently Cross-Linked Hierarchically Folded DNA Condensates.
Ordered DNA condensates assembled with a block copolymer of PEG-poly(l-lysine) hierarchically fold the supercoiled plasmids into anisotropic "nanoworms" that maintain duplex continuity and display sequence-periodic, single-stranded hinges. After irreversible chemical cross-linking to preclude the potential DNA release, these architecturally preserved nanoscale condensates sustain sequence-specific transcription and coupled luciferase translation at efficiencies equaling or surpassing naked DNA, whereas jetPEI-derived disordered spheres remain transcriptionally silent. In both live cells and animals, eGFP-encoding nanoworm-like DNA condensates elicit robust cytosolic expression without requiring structural disassembly for liberation of the DNA payloads, thereby circumventing the obligatory "uncoat-and-release" step and eliminating the potential insertional-mutagenesis risk. These crystalline, nonviral DNA assemblies are postulated to offer a genome-integration-free platform for safer gene therapy.
Read moreA materialized intelligent sensing platform driven by ultra-sensitive fluorescent probe: Smart phone-assisted portable detection of SO2 and its derivatives.
Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer.
PET/CT-guided management of immune checkpoint blockade and post-treatment multi-modal profiling in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).